|
Teva Pharmaceutical Industries Limited - Company Profile Snapshot
| Company Profile: |
Teva Pharmaceutical Industries Limited |
| Ticker: |
TEVA |
| Exchanges: |
TEL |
| 2008 Sales: |
39,500,000,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
ISRAEL |
| Employees: |
38307 |
Business Description
Teva Pharmaceutical Industries Limited. The Group's principal activities are to involve in the development, manufacturing, marketing and distribution of Pharmaceuticals and Active Pharmaceutical Ingredients. The Group operates under two segments: Pharmaceutical and API. Under Pharmaceutical, the Group involves in the development, production, marketing and distribution of drugs in various dosages and forms, in most areas of medicinal treatment and disposable hospital supplies. Under API, the Group involves in the development, production, marketing and distribution of API for the pharmaceutical industry. The Group manufactures solid dosage forms, injectables, liquids, semi-solids and inhalers. The products of the Group include Copaxone and Azilect. The Group operates with 34 dosage pharmaceutical plants in North America, Latin America, Europe, Israel and China. The majority of the Group's sales are in North America and Western Europe. It acquired Barr in 2008.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
